Akums Drugs Plans ₹3,713 Cr IPO With Fresh 5.47 Cr Shares
Akums Drugs Pharmaceuticals plans IPO worth Rs 3,713.47 cr. The IPO includes a fresh issue of 5.47 crore shares. Source: moneycontrol.com
Stock news timeline · AKUMS
Akums Drugs & Pharmaceuticals
News timeline · Last 30 days
24 Aug 2026 – 22 Sep 2026 · Times in IST
- Timeline updates
- 7
- Bullish
- 1
- Neutral
- 6
- Bearish
- 0
- Active days
- 4
News timeline
Showing 7 of 7 updates · Newest first
No matching updates
Change the keyword or sentiment above, then click Apply.
Monday, 21 Sep 20261 update
Wednesday, 16 Sep 20262 updates
Akums Drugs And Pharmaceuticals: To Host Analyst And Investor Meeting On September 22 At 10 AM
Akums Drugs Joins G200 Summit 2026 in Mumbai
Akums Drugs to attend G200 Summit 2026 on Sep 22 in Mumbai. No unpublished price-sensitive info will be shared; details on www.akums.in. Source: BSE
Thursday, 03 Sep 20261 update
Akums Drugs Gets ESG Rating of 65 for FY26 from NSE Sustainability
Akums Drugs received an ESG rating of 65 for FY 2025-26 from NSE Sustainability. The rating was voluntarily assigned based on public data; Akums did not engage NSE Sustainability. Source: BSE
Tuesday, 25 Aug 20263 updates
Akums Drugs Schedules Investor Meet on Sept 2
Akums Drugs to hold analyst, investor meeting on Sept 2. Source: Livesquawk
Akums Drugs And Pharmaceuticals: To Host Meeting With Analysts And Investors On September 2
Akums Drugs to Join 'Ashwamedh 2026' in Mumbai on Sept 2
Akums Drugs to participate in 'Ashwamedh – Elara India Dialogue 2026' on Sept 2, 2026. The group meet will be held physically at Hyatt, Santacruz East, Mumbai. Source: BSE